Stay updated on Pembrolizumab in SCLC Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab in SCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab in SCLC Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    12 days ago
    Change Detected
    Summary
    Added the keyword 'Small cell lung carcinoma' and included a Resources section linking to the Genetic and Rare Diseases Information Center.
    Difference
    0.2%
    Check dated 2026-03-27T23:53:40.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    Revision tag updated from v3.4.3 to v3.5.0 in the page header.
    Difference
    0.1%
    Check dated 2026-03-20T19:59:50.000Z thumbnail image
  4. Check
    26 days ago
    No Change Detected
  5. Check
    33 days ago
    Change Detected
    Summary
    Revision updated from v3.4.2 to v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-06T17:58:01.000Z thumbnail image
  6. Check
    55 days ago
    Change Detected
    Summary
    Revision v3.4.2 was added and v3.4.1 was removed.
    Difference
    0.1%
    Check dated 2026-02-13T12:09:04.000Z thumbnail image
  7. Check
    62 days ago
    Change Detected
    Summary
    Revision label updated from v3.4.0 to v3.4.1; no changes to study details or content are evident. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-05T17:20:34.000Z thumbnail image
  8. Check
    70 days ago
    Change Detected
    Summary
    The changes are minor UI and metadata updates, including a glossary toggle, updated QC criteria wording, capitalization adjustments for No FEAR Act data, and a new revision tag (v3.4.0). To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2026-01-29T06:57:13.000Z thumbnail image

Stay in the know with updates to Pembrolizumab in SCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in SCLC Clinical Trial page.